Job summary (Short promotional text) We are looking for a Junior / Medior Innovation Consultant to strengthen our Life Sciences & Health team in the Netherlands. In this role, you will support innovative companies, research organizations, universities,
Manager Data Science – Corporate Markets, Life Sciences Location: Amsterdam / London Employment type: Full time About the team Elsevier’s mission is to help researchers, clinicians, and life sciences professionals advance discovery and improve health outcomes through trusted content,
Manager Data Science – Corporate Markets, Life Sciences Location: Amsterdam / London Employment type: Full time About the team Elsevier’s mission is to help researchers, clinicians, and life sciences professionals advance discovery and improve health outcomes through trusted content,
Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department.
Company Description For 35 years, we have been developing cutting-edge science and technology to empower biomedical research and personalized medicine. We combine excellence from more than 60 disciplines in natural sciences, engineering, and informatics to significantly contribute to biomedical sciences. We
Work ScheduleStandard (Mon-Fri) Environmental ConditionsOffice Job Description As part of Thermo Fisher Scientific’s mission to enable our customers to make the world healthier, cleaner and safer, the Manager, Regulatory Affairs – EMEA is responsible for leading
Location: Amsterdam, the Netherlands Job type: Full time, Permanent About the job: Join our dynamic team as a full-time Regulatory Affairs (RA) Manager in the Netherlands Dutch team! Under the guidance of Layla Fitoury, our Head
“Are you ready to drive global clinical studies that truly change patients’ ‘lives” At Acerta Pharma, a member of the AstraZeneca Group, we are dedicated to transforming the treatment landscape for patients with haematological malignancies. We